Investing.com — Aligos Therapeutics Inc (ALGS)股价已触及52周低点，跌至6.71美元， InvestingPro ...

Aligos Therapeutics (NASDAQ:ALGS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently ...

对于营收和净利双增长的原因，特宝生物表示，报告期内，公司主业稳健向好，尤其是随着乙肝临床治愈研究的不断深入，公司产品派格宾作为慢性乙肝抗病毒治疗的一线用药，进一步得到专家和患者的认可，产品持续放量，带动经营业绩实现较大增长。

华安证券股份有限公司最近对特宝生物进行深入研究，发布了关于该公司的研究报告，标题为《营收利润稳健高增，内生外延多点布局》，并给予特宝生物买入评级。特宝生物（688278）在2024年取得了显著的业绩增长。

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...

EDT Aligos Therapeutics (ALGS) files to sell 6.25M shares of common stock for holdersLight Up your Portfolio with Spark:Easily identify ...

特宝生物供图全球首个Y型40kD聚乙二醇干扰素-2b注射液、国家1类生物制品拓培非格司亭注射液纵览已上市产品和研发管线，人们不难发现，特宝生物一直深耕病毒性肝炎、恶性肿瘤等免疫相关重大疾病治疗领域。

The live webcast can be accessed in the investors section of the MBX Biosciences website at https://investors.mbxbio.com/news ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, ...

Aligos Therapeutics, Inc announced positive data from three oral presentations at the 34th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL) 2025, being held March ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever 60.4% of Aligos Therapeutics shares are held by institutional investors.